An Immunological Role in the CARDs

Courtesy of Gabriel Nuñez  AND NOW PRESENTING: In this model, microorganisms phagocytosed by the antigen presenting cell (left) release ligands recognized by NOD/CARD proteins and peptides that associate with MHC class II molecules. Recognition of intracellular ligands by NOD/CARD proteins and extracellular ligands by Toll-Like Receptors (TLRs) mediates NF-kB activity. These intracellular events induce cytokine secretion and antigen presentation, as well as the expression of co-stim

Written byJosh Roberts
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

It's rare in this feature to highlight a researcher's work twice in the same year, because it is rare for a researcher to achieve what Gabriel Nuñez's team at the University of Michigan, Ann Arbor, has accomplished. Besides generating at least three Hot Papers on NOD1 and NOD2 in a matter of a few months,1-3 Nuñez helped create the discipline of intracellular pathogen recognition, and influenced the work of scientists in fields as diverse as genetics, innate and mucosal immunity, gastroenterology, and apoptosis research.

Prior to publishing Hot Papers that connected NOD2 mutations and Crohn disease,1 Nuñez and others demonstrated that NOD1 and NOD2 (now officially known as CARD4 and CARD15, respectively) play a role in innate immunity. In these two papers,2,3 Nuñez's team published results arguing that CARD4 and CARD15, both presumably cytosolic proteins, recognize the bacterial cell wall constituent lipopolysaccharide (LPS).2 Further, activating either protein stimulates the immunoregulatory ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies